Bello Alexander, Chand Allan, Aviles Jenna, Soule Geoff, Auricchio Alberto, Kobinger Gary P
1] Public Health Agency of Canada, National Microbiology Laboratory, Special Pathogens Program, Winnipeg, Canada [2] University of Manitoba, Department of Medical Microbiology.
1] Public Health Agency of Canada, National Microbiology Laboratory, Special Pathogens Program, Winnipeg, Canada [2] Department of Immunology, Winnipeg, Canada.
Sci Rep. 2014 Oct 22;4:6644. doi: 10.1038/srep06644.
Recently, development of Adeno-associated virus (AAV) vectors has been focusing on expanding the genetic diversity of vectors from existing sequences via directed evolution or epitope remapping. Apart from intelligent design, AAV isolation from natural sources remains an important source of new AAVs with unique biological features. In this study, several new AAV sequences were isolated from porcine tissues (AAVpo2.1, -po4, -po5, and -po6), which aligned in divergent new clades. Viral particles generated from these sequences displayed tissue tropism and transduction efficiency profile specific to each porcine-derived AAV. When delivered systemically, AAVpo2.1 targeted the heart, kidney, and muscle, AAVpo5 performed poorly but was able to transduce muscle fibers when injected intramuscularly, whereas AAVpo4 and -po6 efficiently transduced all the major organs sampled, contending with 'gold-standard' AAVs. When delivered systemically, AAVpo4 and -po6 were detected by polymerase chain reaction (PCR) and histochemical staining of the transgene product in adult mouse brain, suggesting that these vectors can pass through the blood-brain barrier with efficiencies that may be useful for the development of therapeutic approaches. Porcine tissues are antigenically similar to human tissues and by inference, porcine AAVs may provide fresh tools to contribute to the development of gene therapy-based solutions to human diseases.
最近,腺相关病毒(AAV)载体的开发一直专注于通过定向进化或表位重映射从现有序列扩展载体的遗传多样性。除了智能设计外,从天然来源分离AAV仍然是具有独特生物学特性的新型AAV的重要来源。在本研究中,从猪组织中分离出几种新的AAV序列(AAVpo2.1、-po4、-po5和-po6),它们在不同的新分支中排列。从这些序列产生的病毒颗粒表现出每种猪源AAV特有的组织嗜性和转导效率特征。全身给药时,AAVpo2.1靶向心脏、肾脏和肌肉,AAVpo5表现不佳,但肌肉注射时能够转导肌纤维,而AAVpo4和-po6能有效转导所有采样的主要器官,可与“金标准”AAV相媲美。全身给药时,通过聚合酶链反应(PCR)和转基因产物在成年小鼠脑中的组织化学染色检测到AAVpo4和-po6,这表明这些载体可以穿过血脑屏障,其效率可能有助于治疗方法的开发。猪组织在抗原性上与人类组织相似,据此推断,猪AAV可能为基于基因治疗的人类疾病解决方案的开发提供新工具。